Search

Displaying results 6481 - 6490 of 8517 in total
  1. Drug

    Cilengitide

    go.drugbank.com/drugs/DB11890
    Investigational

    Cilengitide has been used in trials studying the treatment of Sarcoma, Gliomas, Lymphoma, Leukemia, and Lung Cancer, among others.

  2. Drug

    MK-0893

    go.drugbank.com/drugs/DB12044
    Investigational

    MK0893 has been used in trials studying the treatment of Type 2 Diabetes Mellitus and Diabetes Mellitus, Type 2.

  3. Drug

    Lenabasum

    go.drugbank.com/drugs/DB12193
    Investigational

    Ajulemic acid has been used in trials studying the treatment of Cystic Fibrosis, Dermatomyositis, and Diffuse Cutaneous Systemic Sclerosis.

  4. Drug

    Labetuzumab govitecan

    go.drugbank.com/drugs/DB12331
    Investigational

    Labetuzumab govitecan has been used in trials studying the treatment of Colon Cancer, Rectal Cancer, and Metastatic Colorectal Cancer.

  5. Drug

    LY-2599506

    go.drugbank.com/drugs/DB05970
    Investigational

    LY2599506 was under investigation in clinical trials NCT01024244 and NCT01029795 for the treatment of patients with type 2 diabetes.

  6. Drug

    CTS-1027

    go.drugbank.com/drugs/DB08490
    Investigational

    CTS-1027 has been used in trials studying the treatment of Hepatitis C and Chronic Hepatitis C Virus Infection.

  7. Drug

    Sarpogrelate

    go.drugbank.com/drugs/DB12163
    Investigational

    Sarpogrelate has been investigated for the treatment of Diabetes Mellitus, Diabetic Nephropathy, Coronary Artery Disease, and Renal Insufficiency, Chronic.

  8. Drug

    Iomethin I-131

    go.drugbank.com/drugs/DB21079
    Experimental

    Iomethin I-131 has a monoisotopic molecular weight of 359.06 Da.

  9. Drug

    Morphine glucuronide

    go.drugbank.com/drugs/DB06409
    Investigational

  10. Drug

    RPI-78M

    go.drugbank.com/drugs/DB05740
    Experimental

    RPI-78M is being developed for the treatment of multiple sclerosis (MS). Other neurological disorders that may be served by RPI-78M include myasthenia gravis (MG), muscular dystrophy (MD) and amyotrophic lateral sclerosis (ALS).